Literature DB >> 12522044

Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes.

Masahiro Niikura1, Tetsuro Ikegami, Masayuki Saijo, Takeshi Kurata, Ichiro Kurane, Shigeru Morikawa.   

Abstract

Ebola virus consists of four genetically distinguishable subtypes. We developed monoclonal antibodies (MAbs) to the nucleoprotein (NP) of Ebola virus Zaire subtype and analyzed their cross-reactivities to the Reston and Sudan subtypes. We further determined the epitopes recognized by these MAbs. Three MAbs reacted with the three major subtypes and recognized a fragment containing 110 amino acids (aa) at the C-terminal extremity. They did not show specific reactivities to any 10-aa short peptides in Pepscan analyses, suggesting that these MAbs recognize conformational epitope(s) located within this region. Six MAbs recognized a fragment corresponding to aa 361 to 461 of the NP. Five of these six MAbs showed specific reactivities in Pepscan analyses, and the epitopes were identified in two regions, aa 424 to 430 and aa 451 to 455. Three MAbs that recognized the former epitope region cross-reacted with all three subtypes, and one that recognized the same epitope region was Zaire specific. One MAb, which recognized the latter epitope region, was reactive with Zaire and Sudan subtypes but not with the Reston subtype. These results suggest that Ebola virus NP has at least two linear epitope regions and that the recognition of the epitope by MAbs can vary even within the same epitope region. These MAbs showing different subtype specificities might be useful reagents for developing an immunological system to identify Ebola virus subtypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522044      PMCID: PMC145268          DOI: 10.1128/cdli.10.1.83-87.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Outbreak of Ebola haemorrhagic fever, Uganda, August 2000-January 2001.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-02-09

3.  Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.

Authors:  J A Wilson; M K Hart
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Immunofluorescence method for detection of Ebola virus immunoglobulin g, using HeLa cells which express recombinant nucleoprotein.

Authors:  M Saijo; M Niikura; S Morikawa; I Kurane
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.

Authors:  A Sanchez; M P Kiley; B P Holloway; J B McCormick; D D Auperin
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

7.  Epitopes involved in antibody-mediated protection from Ebola virus.

Authors:  J A Wilson; M Hevey; R Bakken; S Guest; M Bray; A L Schmaljohn; M K Hart
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

8.  Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread.

Authors:  R C Baron; J B McCormick; O A Zubeir
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

9.  Ebola virus: identification of virion structural proteins.

Authors:  M P Kiley; R L Regnery; K M Johnson
Journal:  J Gen Virol       Date:  1980-08       Impact factor: 3.891

10.  Infectivity-enhancing antibodies to Ebola virus glycoprotein.

Authors:  A Takada; S Watanabe; K Okazaki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

View more
  12 in total

1.  Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein.

Authors:  Tetsuro Ikegami; Masahiro Niikura; Masayuki Saijo; Mary E Miranda; Alan B Calaor; Marvin Hernandez; Luz P Acosta; Daria L Manalo; Ichiro Kurane; Yasuhiro Yoshikawa; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 2.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

3.  Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Authors:  Eri Nakayama; Ayaka Yokoyama; Hiroko Miyamoto; Manabu Igarashi; Noriko Kishida; Keita Matsuno; Andrea Marzi; Heinz Feldmann; Kimihito Ito; Masayuki Saijo; Ayato Takada
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

4.  Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays.

Authors:  Teddy Kamata; Mohan Natesan; Kelly Warfield; M Javad Aman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-09-17

5.  Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses.

Authors:  Laura E Baker; Jeffrey F Ellena; Katarzyna B Handing; Urszula Derewenda; Darkhan Utepbergenov; Daniel A Engel; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-01-01       Impact factor: 7.652

6.  Nucleoprotein-based indirect enzyme-linked immunosorbent assay (indirect ELISA) for detecting antibodies specific to Ebola virus and Marbug virus.

Authors:  Yi Huang; Youjie Zhu; Mengshi Yang; Zhenqing Zhang; Donglin Song; Zhiming Yuan
Journal:  Virol Sin       Date:  2014-12-15       Impact factor: 4.327

7.  Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.

Authors:  Katendi Changula; Reiko Yoshida; Osamu Noyori; Andrea Marzi; Hiroko Miyamoto; Mari Ishijima; Ayaka Yokoyama; Masahiro Kajihara; Heinz Feldmann; Aaron S Mweene; Ayato Takada
Journal:  Virus Res       Date:  2013-05-20       Impact factor: 3.303

8.  Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.

Authors:  Masayuki Saijo; Marie-Claude Georges-Courbot; Philippe Marianneau; Victor Romanowski; Shuetsu Fukushi; Tetsuya Mizutani; Alain-Jean Georges; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

9.  A Highly Conserved GEQYQQLR Epitope Has Been Identified in the Nucleoprotein of Ebola Virus by Using an In Silico Approach.

Authors:  Mohammad Tuhin Ali; Md Ohedul Islam
Journal:  Adv Bioinformatics       Date:  2015-02-01

10.  Ebolavirus nucleoprotein C-termini potently attract single domain antibodies enabling monoclonal affinity reagent sandwich assay (MARSA) formulation.

Authors:  Laura J Sherwood; Andrew Hayhurst
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.